In-hospital process for viral hepatitis C screening and management in China (Draft).
10.3760/cma.j.cn501113-20210401-00157
- Collective Name:China Liver Health;Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Laboratory Medicine, Chinese Medical Association;Hospital Infection Management Committee of Chinese Hospital Association
- Publication Type:Journal Article
- Keywords:
Algorithm;
Diagnosis;
Hepatitis C;
Screen;
Treatment
- MeSH:
Antiviral Agents/therapeutic use*;
China/epidemiology*;
Hepacivirus/genetics*;
Hepatitis C/epidemiology*;
Hepatitis C, Chronic/epidemiology*;
Hospitals;
Humans;
Liver Neoplasms/drug therapy*
- From:
Chinese Journal of Hepatology
2021;29(4):319-325
- CountryChina
- Language:Chinese
-
Abstract:
Viral hepatitis C is one of the important causes of liver cirrhosis and hepatocellular carcinoma. There are approximately 10 million cases of chronic hepatitis C virus (HCV) infection in China. However, over 70% of HCV infections of China have not yet been detected. According to the goal of "eliminating viral hepatitis as a public health threat by 2030" of the World Health Organization Viral Hepatitis Strategy, and the fact that medical institutions remain the main places for detecting HCV infections or patients in China at present, we established the " In-hospital process for viral hepatitis C screening and management in China (Draft)", with intention to promote the multidisciplinary collaboration and cooperation among the departments of clinic, laboratory, infection control, management, and etc. in medical institutions, and strengthen consultation and referral of patients with detected HCV antibodies and advance the diagnosis and antiviral treatment of patients with chronic hepatitis C.
